Verisante Technology Inc. (VRSEF)
OTCMKTS
· Delayed Price · Currency is USD
0.0011
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EST
Verisante Technology Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
48.33K USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| G Medical Innovations Holdings | 4.42M |
| Rafina Innovations | 335.15K |
| Advanced BioMedical Technologies | 109.84K |
| Telesis Bio | 17.03M |
| Medical Supply International USA | 362.07K |
| Holdco Nuvo Group D.G | 176.00K |
| DIH Holding US | 62.86M |
| Pressure BioSciences | 1.50M |
Verisante Technology News
- 1 year ago - Verisante Technology, Inc. Announces Termination of Proposed RTO with SunRegen Healthcare AG - Accesswire
- 1 year ago - Verisante Technology, Inc. Announces RTO Update: - Accesswire
- 1 year ago - Verisante Technology, Inc. Announces Update to Proposed RTO with SunRegen Healthcare AG - Accesswire
- 1 year ago - Verisante Technology, Inc. Announces Proposed RTO with SunRegen Healthcare AG - Accesswire
- 2 years ago - Verisante Technology, Inc. Announces Exchange Acceptance of Shares for Debt Transaction - Accesswire
- 2 years ago - Verisante Technology, Inc. Announces Shares for Debt Agreements - Accesswire
- 2 years ago - Verisante Technology, Inc. Announces 2023 AGM Results - Accesswire
- 2 years ago - Verisante Technology, Inc. Announces Exchange Approval for Shares for Debt Transaction - Accesswire